Excision BioTherapeutics is a private company focused on developing advanced gene-editing therapeutics to address the medical need for the treatment of life-threatening diseases caused by viral infections.

Biotechnology

Education

Excision BioTherapeutics

Daniel Dornbusch

Pamela Castillo

Karina Dias Teixeira

Franz Gerner

Helen Zhao

William Kennedy

Christine Silverstein

TJ Cradick

Elvin Ruan

Panos Argiras

Qin Xiang

Adam Dunko

Lucas Buchheim-Jurisson

Sara Turken

Corporate Governance and Strategy

Scientific Research and Development

Leadership Team

Teams at Excision BioTherapeutics

Corporate Governance and Strategy

Scientific Research and Development

Leadership Team